Abbott On Track To Reach U.S. DES Market By Late 2007 With ZoMaxx
This article was originally published in The Gray Sheet
Executive Summary
Abbott is counting on the deliverability of its ZoMaxx ABT-578-eluting stent to differentiate it from established competitors in the U.S. market